Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ABBV - Enanta Pharmaceuticals' Q4 Results Pulled Down by AbbVie's Sinking HCV Sales

ABBV - Enanta Pharmaceuticals' Q4 Results Pulled Down by AbbVie's Sinking HCV Sales

AbbVie Inc.

Enanta Pharmaceuticals' (NASDAQ: ENTA) got off to a great start in 2019 with its shares soaring more than 40%. It's been downhill since the first quarter, though. The pharma stock is now down more than 10% year to date.

Any hopes that Enanta's fiscal 2019 fourth-quarter results would help turn things around were dashed on Thursday when the company provided its Q4 update after the market closed. Here are the highlights from the drugmaker's latest quarterly results.

Image Source: Getty Images.

Continue reading
Stock Information
Company Name: AbbVie Inc.
Stock Symbol: ABBV
Market: NYSE
Website: abbvieinvestor.com
Menu
ABBV ABBV Quote ABBV Short ABBV News ABBV Articles ABBV Message Board
Get ABBV Alerts

News, Short Squeeze, Breakout and More Instantly...